We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Yarn Made from Human Tissue Helps Repair Wounds

By HospiMedica International staff writers
Posted on 27 Feb 2020
Yarn grown from human skin cells can be knitted, crocheted, and sewed to create pouches, valves, and tubes, and even perforated membranes, according to a new study.

Developed by researchers at the French National Institute of Health and Medical Research (INSERM; Bordeaux, France), Fountain Therapeutics (Culver City, CA, USA), and other institutions, the “human textile” is made of cell-assembled extracellular matrix (CAM) sheets extracted from cultured adult, human fibroblasts. More...
The biological, yet robust, material can be spun into a mass-produced yarn with a range of physical and mechanical properties for use in a range of clinical applications.

In the study, the researchers showed that the material can be used as a simple suture to close a wound, or even nitted into fully biological, human, implantable tissue-engineered vascular grafts (TEVGs) with mechanical burst pressure, suture retention strength, and transmural permeability that surpass clinical requirements. The yarn was also used to stitch up a rat’s wound, with the wound healing fully over the course of two weeks. IN addition, the researchers created a skin graft, using a custom-designed loom, to successfully stop a sheep’s artery from leaking. The study was published on January 26, 2020, in Acta Biomaterialia.

“By combining this truly ‘bio’ material with a textile-based assembly, this original tissue engineering approach is highly versatile and can produce a variety of strong human textiles that can be readily integrated in the body,” concluded senior author Nicolas L'Heureux, PhD, of INSERM, and colleagues. “This novel strategy holds the promise of a next generation of medical textiles that will be mechanically strong without any foreign scaffolding, and will have the ability to truly integrate into the host's body.”

The ECM is a collection of extracellular molecules that provides structural and biochemical support to the surrounding cells. It includes the interstitial matrix, composed of polysaccharide gels and fibrous proteins, and the basement membrane, which are sheet-like depositions on which various epithelial cells rest. Each type of connective tissue in animals has a different ECM; collagen fibers and bone mineral comprise the ECM of bone tissue; reticular fibers and ground substance comprise the ECM of loose connective tissue; and blood plasma is the ECM of blood.

Related Links:
French National Institute of Health and Medical Research
Fountain Therapeutics



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Surgical Headlight
IsoTorch
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.